The 21st international congress on Progress in Vaccination against Cancer (PIVAC-22, https://www.pivac22.it/) was held from September 26 to September 28, 2022, at the Molecular Biotechnology Center "Guido Tarone" in Turin, Italy. The meeting covered the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, and addressed how alterations to the microenvironment's molecular and metabolic features and the microbiota impact upon the response to immunotherapy.
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy
Cavallo, Federica
;Conti, Laura;Quaglino, ElenaLast
2022-01-01
Abstract
The 21st international congress on Progress in Vaccination against Cancer (PIVAC-22, https://www.pivac22.it/) was held from September 26 to September 28, 2022, at the Molecular Biotechnology Center "Guido Tarone" in Turin, Italy. The meeting covered the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, and addressed how alterations to the microenvironment's molecular and metabolic features and the microbiota impact upon the response to immunotherapy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2768-6698-27-12-338.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
240.75 kB
Formato
Adobe PDF
|
240.75 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
